Recent News About Williams & Connolly View More
Lawyer's widow: Recent Supreme Court ruling means she should get $3M in lawsuit vs drugmaker GSK over Paxil labeling
SCOTUS ruling changed "approach" to drug labeling questions, plaintiffs said. GSK says the change wasn't "extraordinary" enough and would open "floodgates" to attempts at lawsuit "do-overs."
Judges said the jury award wasn't excessive, as woman claimed discontinued product left her with permanent injuries and pain.
The widow of a lawyer who took his own life, allegedly after taking the generic equivalent of widely prescribed antidepressant drug, Paxil, will not get a chance to undo a federal appeals court’s decision to toss out a federal jury’s findings that GSK, the maker of Paxil, owes her $3 million because it allegedly didn’t push federal regulators hard enough to revise the drug’s warning label.
SCOTUS weighs competing briefs in widow's appeal in case vs GSK over suicide of lawyer taking generic Paxil
The U.S. Supreme Court is tackling the question of whether drug companies can be sued for not making their warning labels strong enough, even though the FDA controls the labels. But whether a forthcoming Supreme Court decision will affect a decision denying a $3 million judgment to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of Paxil remains unclear.